Clinical trials
Hereditary Sensory and Autonomic Neuropathies trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| AllRock Bio, Inc. | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| AstraZeneca | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Haihe Biopharma Co., Ltd. | 1 |
| Incyte Corporation | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Revolution Medicines, Inc. | 1 |
| Sanford Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hereditary Sensory and Autonomic Neuropathies | 13 |
| Breast Neoplasms | 2 |
| Congenital Abnormalities | 2 |
| Lymphoma, Follicular | 2 |
| Ovarian Neoplasms | 2 |
| Addison Disease | 1 |
| Alagille Syndrome | 1 |
| Alstrom Syndrome | 1 |
| Amnesia, Transient Global | 1 |
| Aniridia | 1 |
Trials
Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.